Neumora Therapeutics
NMRA
$9.67
Share price
0.42%
Change (1 day)
N/A
Change (1 year)
Categories
Neumora Therapeutics (NMRA) - Cash on Hand
Cash on Hand as of December 2023 : $0.45 B
According to Neumora Therapeutics's latest financial reports the company has $0.45 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Neumora Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.45 B | 22.08% |
| 2022-12-31 | $0.37 B | -9.13% |
| 2021-12-31 | $0.40 B | 113.18% |
| 2020-12-31 | $0.19 B | |
| 2019-12-31 | $N/A |